{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:33:15Z","timestamp":1791304395582,"version":"4.3.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Basal cell naevus syndrome (BCNS) is a rare autosomal dominant condition characterized by early onset and multiple basal cell carcinomas (BCCs), skeletal and ocular abnormalities, and extracutaneous tumours and cysts. In most cases, BCNS is caused by a pathogenic variant in the tumour suppressor gene PTCH1. Pathogenic variants in SUFU account for a minority of cases. No clear genotype\u2013phenotype associations between different PTCH1 variants have been established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify all individuals with BCNS in Norway, characterize their clinical and genetic profiles, and investigate possible genotype\u2013phenotype associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study, we approached all individuals with BCNS registered at the Department of Dermatology at Oslo University Hospital and two national resource centres for rare medical conditions. Dermatologists, dentists and geneticists across Norway were contacted in order to identify additional individuals with BCNS. Data were collected from structured interviews, whole-body physical examinations, electronic medical records, radiographic imaging and molecular genetic analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 109 individuals with BCNS, indicating a national prevalence of BCNS of at least 1.9 per 100 000, of whom 103 agreed to be included. Clinical findings confirmed the considerable phenotypic variation in BCNS, including BCC in 61 individuals (median number of BCCs 48, range 1\u20131025), odontogenic keratocysts in 72 (median number of odontogenic keratocysts 5, range 1\u201330) and a wide spectrum of ocular and skeletal abnormalities in 43 and 98 individuals, respectively. This study is the first to report the prevalence estimates of autism (4%) and epilepsy (7%), as well as intracranial lesions associated with epilepsy, in BCNS. Genetic analyses identified a pathogenic or probable pathogenic PTCH1 variant in 93 individuals, while 5 individuals had variants of uncertain clinical significance. Twenty-one of the pathogenic PTCH1 variants were novel. None of the individuals with PTCH1 variants in exon 1, all belonging to the same family, exhibited BCCs, odontogenic keratocysts or palmoplantar pitting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study expands the number of pathogenic PTCH1 variants, elucidates important clinical aspects in BCNS and reveals novel insight to genotype\u2013phenotype associations, providing new implications for management and follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjd\/ljaf413","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:57:56Z","timestamp":1761134276000},"page":"264-272","source":"Crossref","is-referenced-by-count":3,"title":["Clinical and genetic findings in 103 individuals in Norway with basal cell naevus syndrome"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4448-5339","authenticated-orcid":false,"given":"Karianne Haga","family":"Brandtz\u00e6g","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]},{"name":"Department of Dermatology, Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3176-0160","authenticated-orcid":false,"given":"Charlotte","family":"von der Lippe","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Telemark Hospital , Skien ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4575-7221","authenticated-orcid":false,"given":"Ingvild Kibsgaard","family":"Vestengen","sequence":"additional","affiliation":[{"name":"Norwegian National Resource Center for Oral Health in Rare Disorders, Lovisenberg Diaconal Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7731-0750","authenticated-orcid":false,"given":"Josephine Prener","family":"Holtan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-8886","authenticated-orcid":false,"given":"Mona Irene","family":"Winge","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7903-9087","authenticated-orcid":false,"given":"Cecilie F","family":"Rustad","sequence":"additional","affiliation":[{"name":"Centre for Rare Disorders, Oslo University Hospital ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5892-5813","authenticated-orcid":false,"given":"Tone Kristin","family":"Bergersen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]},{"name":"Department of Dermatology, Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7194-3570","authenticated-orcid":false,"given":"Solrun","family":"Sigurdardottir","sequence":"additional","affiliation":[{"name":"Centre for Rare Disorders, Oslo University Hospital ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3880-6440","authenticated-orcid":false,"given":"Wenche","family":"Sjursen","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, St Olav\u2019s University Hospital , Trondheim ,","place":["Norway"]},{"name":"Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology , Trondheim ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3596-9829","authenticated-orcid":false,"given":"Petter","family":"Gjersvik","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4423-6871","authenticated-orcid":false,"given":"Kristin\u00a0Halvorsen","family":"Hortemo","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo , Oslo ,","place":["Norway"]},{"name":"Department of Dermatology, Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"2026012706480716000_ljaf413-B1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bjd.20700","article-title":"A guideline for the clinical management of basal cell naevus syndrome (Gorlin\u2013Goltz syndrome)","volume":"186","author":"Verkouteren","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026012706480716000_ljaf413-B2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/jmg.30.6.460","article-title":"Complications of the naevoid basal cell carcinoma syndrome: results of a population based study","volume":"30","author":"Evans","year":"1993","journal-title":"J Med Genet"},{"key":"2026012706480716000_ljaf413-B3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M","article-title":"Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome","volume":"69","author":"Kimonis","year":"1997","journal-title":"Am J Med Genet"},{"key":"2026012706480716000_ljaf413-B4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ajmg.1320500312","article-title":"Nevoid basal cell carcinoma syndrome: review of 118 affected individuals","volume":"50","author":"Shanley","year":"1994","journal-title":"Am J Med Genet"},{"key":"2026012706480716000_ljaf413-B5","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/ajmg.a.34128","article-title":"Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS)","volume":"155a","author":"Bree","year":"2011","journal-title":"Am J Med Genet A"},{"key":"2026012706480716000_ljaf413-B6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0140-6736(92)90868-4","article-title":"Location of gene for Gorlin syndrome","volume":"339","author":"Farndon","year":"1992","journal-title":"Lancet"},{"key":"2026012706480716000_ljaf413-B7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0092-8674(92)90122-S","article-title":"Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9","volume":"69","author":"Gailani","year":"1992","journal-title":"Cell"},{"key":"2026012706480716000_ljaf413-B8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0092-8674(00)81268-4","article-title":"Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome","volume":"85","author":"Hahn","year":"1996","journal-title":"Cell"},{"key":"2026012706480716000_ljaf413-B9","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.272.5268.1668","article-title":"Human homolog of patched, a candidate gene for the basal cell nevus syndrome","volume":"272","author":"Johnson","year":"1996","journal-title":"Science"},{"key":"2026012706480716000_ljaf413-B10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrc2503","article-title":"Basal cell carcinomas: attack of the hedgehog","volume":"8","author":"Epstein","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2026012706480716000_ljaf413-B11","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1200\/JCO.2014.58.2569","article-title":"Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations","volume":"32","author":"Smith","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"2026012706480716000_ljaf413-B12","article-title":"Nevoid basal cell carcinoma syndrome","author":"Evans","journal-title":"GeneReviews\u00ae"},{"key":"2026012706480716000_ljaf413-B13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ajmg.a.34421","article-title":"Nationwide survey of nevoid basal cell carcinoma syndrome in Japan revealing the low frequency of basal cell carcinoma","volume":"158a","author":"Endo","year":"2012","journal-title":"Am J Med Genet A"},{"key":"2026012706480716000_ljaf413-B14","doi-asserted-by":"crossref","first-page":"217378","DOI":"10.1155\/2011\/217378","article-title":"Basal cell carcinomas in Gorlin syndrome: a review of 202 patients","volume":"2011","author":"Jones","year":"2011","journal-title":"J Skin Cancer"},{"key":"2026012706480716000_ljaf413-B15","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1200\/JCO.21.02385","article-title":"Gorlin syndrome: assessing genotype\u2013phenotype correlations and analysis of early clinical characteristics as risk factors for disease severity","volume":"40","author":"Betancourt","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"2026012706480716000_ljaf413-B16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2019.07.072","article-title":"Lack of genotype\u2013phenotype correlation in basal cell nevus syndrome: a Dutch multicenter retrospective cohort study","volume":"83","author":"Cosgun","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026012706480716000_ljaf413-B17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jmedgenet-2017-104669","article-title":"First evidence of genotype\u2013phenotype correlations in Gorlin syndrome","volume":"54","author":"Evans","year":"2017","journal-title":"J Med Genet"},{"key":"2026012706480716000_ljaf413-B18","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/mgg3.498","article-title":"Whole-exome sequencing of nevoid basal cell carcinoma syndrome families and review of Human Gene Mutation Database PTCH1 mutation data","volume":"6","author":"Gianferante","year":"2018","journal-title":"Mol Genet Genomic Med"},{"key":"2026012706480716000_ljaf413-B19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"18","author":"Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"key":"2026012706480716000_ljaf413-B20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2026012706480716000_ljaf413-B21","author":"Durkie"},{"key":"2026012706480716000_ljaf413-B22","author":"Statistics Norway"},{"key":"2026012706480716000_ljaf413-B23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/epi.12972","article-title":"Prevalence and etiology of epilepsy in a Norwegian county \u2013 a population based study","volume":"56","author":"Syvertsen","year":"2015","journal-title":"Epilepsia"},{"key":"2026012706480716000_ljaf413-B24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0404.2007.00909.x","article-title":"Age-specific prevalence of epilepsy in Oppland County, Norway","volume":"116","author":"Svendsen","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"2026012706480716000_ljaf413-B25","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.4045\/tidsskr.13.0050","article-title":"Differences across counties in the registered prevalence of autism, ADHD, epilepsy and cerebral palsy in Norway","volume":"133","author":"Sur\u00e9n","year":"2013","journal-title":"Tidsskr Nor Laegeforen"},{"key":"2026012706480716000_ljaf413-B26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10689-021-00247-z","article-title":"Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG)","volume":"20","author":"Guerrini-Rousseau","year":"2021","journal-title":"Fam Cancer"},{"key":"2026012706480716000_ljaf413-B27","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1097\/SCS.0000000000004274","article-title":"Novel PTCH1 gene mutation in nevoid basal cell carcinoma syndrome","volume":"29","author":"Sim","year":"2018","journal-title":"J Craniofac Surg"},{"key":"2026012706480716000_ljaf413-B28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s10038-018-0485-0","article-title":"PTCH1 isoform 1b is the major transcript in the development of basal cell nevus syndrome","volume":"63","author":"Gielen","year":"2018","journal-title":"J Hum Genet"},{"key":"2026012706480716000_ljaf413-B29","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1038\/sj.onc.1205865","article-title":"Alternative first exons of\u00a0PTCH1 are differentially regulated in vivo and may confer \u00addifferent functions to the PTCH1 protein","volume":"21","author":"Kogerman","year":"2002","journal-title":"Oncogene"},{"key":"2026012706480716000_ljaf413-B30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.oooo.2015.05.024","article-title":"A systematic review of the literature of nevoid basal cell carcinoma syndrome affecting East Asians and North Europeans","volume":"120","author":"MacDonald","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2026012706480716000_ljaf413-B31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000444792","article-title":"Nevoid basal cell carcinoma syndrome: report from the Zurich nevoid basal cell carcinoma syndrome cohort","volume":"232","author":"Rehefeldt-Erne","year":"2016","journal-title":"Dermatology"},{"key":"2026012706480716000_ljaf413-B32","first-page":"e84","article-title":"Novel clinical and molecular findings in Spanish patients with nevoid basal cell carcinoma syndrome","volume":"178","author":"Alonso","year":"2018","journal-title":"Br J Dermatol"},{"key":"2026012706480716000_ljaf413-B33","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/ijd.15884","article-title":"Basal cell nevus syndrome: an update on clinical findings","volume":"61","author":"Fern\u00e1ndez","year":"2022","journal-title":"Int J Dermatol"},{"key":"2026012706480716000_ljaf413-B34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/1346-8138.15892","article-title":"Basaloid follicular hamartomas in pediatric basal cell nevus syndrome: a diagnostic challenge","volume":"48","author":"Besagni","year":"2021","journal-title":"J\u00a0Dermatol"},{"key":"2026012706480716000_ljaf413-B35","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1111\/1346-8138.16321","article-title":"Hairy patches as early dermatological signs of Gorlin syndrome in a patient with a novel PTCH1 genetic variant","volume":"49","author":"Couselo-Rodr\u00edguez","year":"2022","journal-title":"J Dermatol"},{"key":"2026012706480716000_ljaf413-B36","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1111\/pde.13067","article-title":"Nevoid basal cell carcinoma syndrome and hairy skin patches","volume":"34","author":"Notay","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"2026012706480716000_ljaf413-B37","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/ajmg.a.31374","article-title":"Patched mutations and hairy skin patches: a new sign in Gorlin syndrome","volume":"140","author":"Wilson","year":"2006","journal-title":"Am J Med Genet A"},{"key":"2026012706480716000_ljaf413-B38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3368\/aoj.63.1.73","article-title":"Efficacy of modified cover testing for detection of incipient true strabismus with pseudostrabismus diagnosis","volume":"63","author":"Pritchard","year":"2013","journal-title":"Am Orthopt J"},{"key":"2026012706480716000_ljaf413-B39","doi-asserted-by":"crossref","first-page":"19791","DOI":"10.1038\/s41598-021-98752-9","article-title":"Proposed criteria for nevoid basal cell carcinoma syndrome in children assessed using statistical optimization","volume":"11","author":"Gold","year":"2021","journal-title":"Sci Rep"},{"key":"2026012706480716000_ljaf413-B40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ncponc0608","article-title":"Rhabdomyosarcoma, Wilms tumor, and deletion of the patched gene in Gorlin syndrome","volume":"3","author":"Cajaiba","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"2026012706480716000_ljaf413-B41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ana.410110409","article-title":"Nevoid basal cell carcinoma syndrome and epilepsy","volume":"11","author":"Murphy","year":"1982","journal-title":"Ann Neurol"},{"key":"2026012706480716000_ljaf413-B42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3988\/jcn.2017.13.4.439","article-title":"Unusual neurological presentation of nevoid basal cell carcinoma syndrome (Gorlin\u2013Goltz syndrome)","volume":"13","author":"Pennisi","year":"2017","journal-title":"J Clin Neurol"},{"key":"2026012706480716000_ljaf413-B43","first-page":"235","article-title":"Gorlin\u2013Goltz syndrome in a child: case report and clinical review","volume":"91","author":"Snoeckx","year":"2008","journal-title":"JBR-BTR"},{"key":"2026012706480716000_ljaf413-B44","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s10038-018-0508-x","article-title":"Co-occurrence of mutations in FOXP1 and PTCH1 in a girl with extreme megalencephaly, callosal dysgenesis and profound intellectual disability","volume":"63","author":"Zombor","year":"2018","journal-title":"J Hum Genet"},{"key":"2026012706480716000_ljaf413-B45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"2026012706480716000_ljaf413-B46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1399-0004.1999.550106.x","article-title":"Nevoid basal cell carcinoma syndrome. Clinical findings in 37 Italian affected individuals","volume":"55","author":"Lo Muzio","year":"1999","journal-title":"Clin Genet"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf413\/64882947\/ljaf413.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/2\/264\/64882947\/ljaf413.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/2\/264\/64882947\/ljaf413.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:48:19Z","timestamp":1769514499000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/2\/264\/8300276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,23]]},"published-print":{"date-parts":[[2026,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf413","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,23]]}}}